Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928598 · ClinicalTrials.gov registry record · NA
Goals for Epilepsy Clinic Visits Trial
A NA study of Drug Resistant Epilepsy, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT05928598 is a NA study of Drug Resistant Epilepsy that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 152 participants, above the 11-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (1282% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05928598, a NA study of Drug Resistant Epilepsy, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the "Epilepsy Visit Planner") have improved outcomes compared to patients that do not receive the tool. The project's hypotheses are: * Patients that receive the Epilepsy Visit Planner will have improved patient-provider communication compared to the non-planner group. * Patients that receive the Epilepsy Visit Planner will have improved quality of life scores. * The Epilepsy Visit Planner will score highly on process measures of feasibility and acceptability, demonstrating suitability for future larger scale study. Additionally, there is a related survey project that is not part of the clinical trial and will not be included in this registration information.
Conditions Studied
Interventions
- BEHAVIORAL Survey questionnaires
- BEHAVIORAL Epilepsy Visit Planner
- BEHAVIORAL Questionnaires for Providers
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2023-09-27 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05928598
The ClinicalTrials.gov registry entry for NCT05928598 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 11-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (1282% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug Resistant Epilepsy appearing as the primary indexed condition, and to 3 interventions - of which Survey questionnaires is the first listed.
NCT05928598 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05928598 about?
NCT05928598 is a clinical study titled "Goals for Epilepsy Clinic Visits Trial". The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the "Epilepsy Visit Planner") have improved outcomes compared to patients that do not receive the tool. The project's hypotheses are: * Patients that r...
What is the current status of trial NCT05928598?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2023-09-27. Estimated completion is 2027-01-01.
What conditions does trial NCT05928598 study?
This clinical trial studies the following conditions: Drug Resistant Epilepsy.
What interventions are being tested in trial NCT05928598?
The interventions under investigation include: Survey questionnaires (BEHAVIORAL), Epilepsy Visit Planner (BEHAVIORAL), Questionnaires for Providers (BEHAVIORAL).
Who is sponsoring clinical trial NCT05928598?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05928598 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Resistant Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial
RECRUITING · NA
-
Infrared Photobiomodulation in Humans With Epilepsy
RECRUITING · NA
-
Novel Helmet Design in Patients With Seizures
COMPLETED · NA
-
Electrophysiologic Studies of Cognition in Epilepsy Patients
COMPLETED · NA
-
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
RECRUITING · Phase 2
-
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.